King Charles reports positive progress amid cancer battle

Pre-recorded broadcast highlights early detection and screening importance

King Charles reports positive progress amid cancer battle
King Charles reports positive progress amid cancer battle

King Charles has delivered a heartfelt and rare personal message through international media, offering insight into his battle with cancer and sharing encouraging updates on his treatment.

The pre-recorded message, filmed at Clarence House, also emphasized the importance of early detection and regular cancer screening, Buckingham Palace confirmed.

The 76-year-old monarch was first diagnosed with an unspecified form of cancer following tests after a corrective procedure for an enlarged prostate in February 2024.

Buckingham Palace reported that His Majesty has responded exceptionally well to treatment, and doctors have advised that his ongoing therapy will now shift to a precautionary phase, allowing for a reduction in treatment intensity over the coming year.

King Charles resumed public duties in April 2025 after a period away, attending ceremonies, official engagements, and international visits while continuing his treatment.

His first public appearance following the diagnosis was at University College Hospital’s Macmillan Cancer Centre, where he was also named the new patron of Cancer Research UK.

The broadcast aired on Channel 4 as part of the Stand Up to Cancer campaign in partnership with Cancer Research UK.

Buckingham Palace highlighted that the king’s candid reflections are intended to raise awareness about cancer, underline the value of early intervention, and inspire the public.

In previous statements, King Charles remarked that his personal experience with cancer revealed “the very best of humanity.” Leading charities, including Maggie’s, praised both the king and Kate Middleton for openly sharing their journeys, noting that their transparency has encouraged patients to speak about their own struggles, offering hope and motivation to countless people.